Pharmacology, Toxicology and Pharmaceutical Science
Androgen
44%
Androgen Receptor
5%
Biological Marker
6%
Calcitriol
17%
Castration Resistant Prostate Cancer
7%
Chemotherapy
21%
Diethylstilbestrol
5%
Disease
15%
Docetaxel
33%
Gleason Score
5%
Malignant Neoplasm
16%
Mitoxantrone
9%
Neoplasm
14%
Overall Survival
10%
Placebo
7%
Prostate Cancer
100%
Prostate Specific Antigen
27%
Transdermal
5%
Medicine and Dentistry
Androgen
24%
Androgen Deprivation Therapy
10%
Biopsy
13%
Brachytherapy
6%
Calcitriol
7%
Disease
15%
Docetaxel
16%
External Beam Radiotherapy
7%
Gleason Score
8%
Lymph Node
6%
Malignant Neoplasm
18%
Mitoxantrone
5%
Needle Biopsy
5%
Neoplasm
18%
Overall Survival
7%
Prostate Biopsy
6%
Prostate Cancer
75%
Prostate Carcinoma
7%
Prostate Specific Antigen
21%
Prostatectomy
17%
Radiation Therapy
10%
Recurrence Free Survival
6%
Recurrent Disease
6%
Keyphrases
Abarelix
6%
Androgen Deprivation Therapy
5%
Calcitriol
5%
Chemotherapy
11%
Confidence Interval
6%
Docetaxel
15%
High Risk
8%
High-grade Prostate Cancer
15%
Hormone-sensitive Prostate Cancer
12%
Prostate Cancer
20%
Prostate Cancer Cells
7%
Prostate Cancer Risk
7%
Prostate-specific Antigen
13%
Prostatectomy
7%
Total Prostate-specific Antigen
6%